Skip to main content
Clinical Trials/IRCT20201001048894N1
IRCT20201001048894N1
Completed
Phase 2

Evaluation of treatment regimen containing beta-1-b interferon on the COVID-19 patients with mild and severe symptoms and comparing it with interferon-free treatment regimen

Bandare-abbas University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Completed
Sponsor
Bandare-abbas University of Medical Sciences
Enrollment
90

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • Positive result of Real time PCR
  • CT severity scoring
  • P o2 \< 93mmHg
  • Respiratory rate more than 30 time per minute.

Exclusion Criteria

  • Cardiac diseases
  • Consumption of corticosteroids

Investigators

Sponsor
Bandare-abbas University of Medical Sciences

Similar Trials